BIA responds to cash injection of €117m to eight coronavirus projects by the European Commission
Commenting on today’s announcement of €117 million awarded to eight coronavirus projects by the European Commission, Steve Bates OBE, Chief Executive of the BIA said:
“Given the integrated nature of the European innovation ecosystem, it’s heartening and no surprise to see that five of the eight EU coronavirus innovation projects announced today have UK involvement and two are led by UK organisations. Coronavirus research shows the clear benefit to all of continued close co-operation between life science innovators in the UK and EU.”
Notes to Editors
1. For more information please contact Shannon Quinney, Communications Executive on firstname.lastname@example.org or 07864902930.
2. The Innovative Medicines Initiative (IMI) has selected eight coronavirus research projects to receive a total of €117 million from public-private money, the Commission announced today.
3. Details of the coronavirus research projects can be found here.
About the BIA
Established over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.